Evidence map›Paper›PMID 28049726›Full record

ArticleThe Journal of biological chemistry2017

Biochemical Evidence for a Nuclear Modifier Allele (A10S) in TRMU (Methylaminomethyl-2-thiouridylate-methyltransferase) Related to Mitochondrial tRNA Modification in the Phenotypic Manifestation of Deafness-associated 12S rRNA Mutation.

Feilong Meng, Xiaohui Cang, Yanyan Peng, Ronghua Li, Zhengyue Zhang, Fushan Li, Qingqing Fan, Anna S Guan, Nathan Fischel-Ghosian, Xiaoli Zhao and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Late onset of type 2 diabetes is associated with mitochondrial tRNAJournal of clinical laboratory analysis · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. [Progress in genetic susceptibility to aminoglycoside-induced deafness].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Feilong MengFrom the Division of Medical Genetics and Genomics, Zhejiang Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
Xiaohui CangFrom the Division of Medical Genetics and Genomics, Zhejiang Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
Yanyan Pengthe Institute of Genetics and.
Ronghua Lithe Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30307.
Zhengyue Zhangthe Institute of Genetics and.
Fushan Lithe Institute of Genetics and.
Qingqing Fanthe Institute of Genetics and.
Anna S Guanthe Ahmanson Department of Pediatrics, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California 90095, and.
Nathan Fischel-Ghosianthe Ahmanson Department of Pediatrics, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California 90095, and.
Xiaoli Zhaothe Institute of Genetics and zhaoxiaoli@zju.edu.cn.
Min-Xin GuanFrom the Division of Medical Genetics and Genomics, Zhejiang Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China, gminxin88@zju.edu.cn.
Children's Hospital of Zhejiang University · CNCedars-Sinai Medical Center · USCincinnati Children's Hospital Medical Center · USEmory University · US

Funding

Molecular Mechanism of Aminoglycoside OtotoxicityR01DC005230 · NIDCD · CINCINNATI CHILDRENS HOSP MED CTR · PI GUAN, MIN-XIN · 2002 to 2006
$1.8M
Nuclear modifier genes for maternally inherited deafnessR01DC007696 · NIDCD · CINCINNATI CHILDRENS HOSP MED CTR · PI GUAN, MIN-XIN · 2007 to 2010
$1.3M
NIDCD NIH HHS R01 DC005230NIDCD NIH HHS R01 DC007696
6 · The paper itself

Abstract

Nuclear modifier gene(s) was proposed to modulate the phenotypic expression of mitochondrial DNA mutation(s). Our previous investigations revealed that a nuclear modifier allele (A10S) in TRMU (methylaminomethyl-2-thiouridylate-methyltransferase) related to tRNA modification interacts with 12S rRNA 1555A→G mutation to cause deafness. The A10S mutation resided at a highly conserved residue of the N-terminal sequence. It was hypothesized that the A10S mutation altered the structure and function of TRMU, thereby causing mitochondrial dysfunction. Using molecular dynamics simulations, we showed that the A10S mutation introduced the Ser

Indexed as

AllelesMutationPhenotypeAminoacylationDeafnessEnzyme StabilityFluorometryHumansMitochondriaMitochondrial ProteinsMolecular Dynamics SimulationRNA, RibosomalRNA, TransfertRNA MethyltransferasesMitochondrial ProteinsRNA, RibosomalRNA, ribosomal, 12SRNA, TransferTRMU protein, humantRNA Methyltransferaseshearingmitochondrial diseasemitochondrial DNA (mtDNA)molecular modelingoxygen radicalspost-translational modification (PTM)respirationribosomal ribonucleic acid (rRNA) (ribosomal RNA)transfer RNA (tRNA)translation

Identifiers

PMID28049726
PMCPMC5314183
OpenAlexW2562169713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.